BioSpace News Archive

Employer Resources

How Salary Transparency Can Help Employers Find and Keep Top Talent

From the initial interview to the annual raise, discussions about salary are vital in every work environment. Find out how implementing salary transparency can help you find and keep top talent.

July 18, 2022
·
4 min read
·
Kaley Lefevre
Drug Development

Is it the End of the Road for Sesen Bio’s Lead Asset?

In what it is calling a strategic decision, Sesen Bio announced Monday that it has paused development activities of Vicineum, its lead asset, in the United States.

July 18, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

Mulling New GSK’s Future after Spinoff Haleon Hits London Stock Exchange

GSK, whose shares were up about 3.3% Monday, will likely use part of the 7 billion pounds it will generate via the Haleon spinoff to make acquisitions.

July 18, 2022
·
4 min read
·
Mark Terry
NASA’s Solution to Stem Cell Production is Out of this World

NASA and Cedars-Sinai Medical Center have sent stem cells into space in order to determine whether they grow differently without G-force.

July 18, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Business

Editas Appoints “Hardcore Clinician-Scientist” Baisong Mei as CMO

Five weeks after taking the reins as CEO of CRISPR-focused Editas Medicine, Gilmore O’Neill fulfilled his first task, appointing a new chief medical officer.

July 18, 2022
·
4 min read
·
Alex Keown
Business

Who is Nestlé Health Science and How Do They Play in Biopharma?

In the latest in Nestlé’s efforts to establish a presence in the gastroenterology space, the company will pay over $40 million upfront to Enterome as part of a new partnership.

July 18, 2022
·
3 min read
·
Tristan Manalac
Researchers Find Link Between Heart Disease and Loss of Y Chromosome in Men

This type of Y chromosome loss is called mLOY (mosaic Loss Of Y). Mosaic refers to a mix of chromosomally different cells, with some being 46,XY and others being 45,X,-Y.

July 18, 2022
·
3 min read
·
Mark Terry
Business

Merck’s Potential Buyout of Seagen Likely Delayed Until End of July

The delay is due, in part, to some internal Seagen actions, including a data readout for its bladder cancer drug Padcev, as well as a legal matter between Seagen and Daiichi Sankyo.

July 18, 2022
·
3 min read
·
Alex Keown
Prescription Stimulants for ADHD: Separating Fact from Fiction

There are myriad misconceptions about prescription stimulants for ADHD. But buried within the array of opinions, as with many hot-button topics, are small nuggets of truth.

July 18, 2022
·
10 min read
·
Rosemary Scott
Business

MEI Pharma and Kyowa Kirin Announce Publication in The Lancet Oncology of Data from Phase 1b Clinical Study of Zandelisib in Patients with Relapsed or Refractory B-cell Malignancy

MEI Pharma, Inc. and Kyowa Kirin Co., Ltd. today announced publication of data from the Phase 1b clinical study of zandelisib, an orally administered investigational phosphatidylinositol 3-kinase delta (“PI3Kδ”) inhibitor.

July 18, 2022
·
10 min read